Peng, T.-R.; Weng, Y.-F.; Wu, T.-W.; Wu, C.-C.; Hsu, C.-L.; Hsu, C.-S.
Efficacy of Transarterial Chemoembolization Combined with Tyrosine Kinase Inhibitors for Hepatocellular Carcinoma: A Systematic Review and Meta-Analysis. Cancers 2025, 17, 2110.
https://doi.org/10.3390/cancers17132110
AMA Style
Peng T-R, Weng Y-F, Wu T-W, Wu C-C, Hsu C-L, Hsu C-S.
Efficacy of Transarterial Chemoembolization Combined with Tyrosine Kinase Inhibitors for Hepatocellular Carcinoma: A Systematic Review and Meta-Analysis. Cancers. 2025; 17(13):2110.
https://doi.org/10.3390/cancers17132110
Chicago/Turabian Style
Peng, Tzu-Rong, Yi-Fang Weng, Ta-Wei Wu, Chao-Chuan Wu, Chia-Lu Hsu, and Ching-Sheng Hsu.
2025. "Efficacy of Transarterial Chemoembolization Combined with Tyrosine Kinase Inhibitors for Hepatocellular Carcinoma: A Systematic Review and Meta-Analysis" Cancers 17, no. 13: 2110.
https://doi.org/10.3390/cancers17132110
APA Style
Peng, T.-R., Weng, Y.-F., Wu, T.-W., Wu, C.-C., Hsu, C.-L., & Hsu, C.-S.
(2025). Efficacy of Transarterial Chemoembolization Combined with Tyrosine Kinase Inhibitors for Hepatocellular Carcinoma: A Systematic Review and Meta-Analysis. Cancers, 17(13), 2110.
https://doi.org/10.3390/cancers17132110